Brief Bio of Dr. William Yang

William H. Yang, MD, FRCPC, FAAAAI

Chair, Red Maple Trials Inc.

Ottawa, Ontario, Canada

Dr. William Yang, MD, FRCPC, FAAAAI, has been active in clinical practice, research and teaching in Ottawa. He completed his Internal Medicine training at the University of Western Ontario and Allergy and Clinical Immunology research training at McGill University. He is the former head, Section of Allergy & Clinical Immunology, University of Ottawa Medical School. He is a past President of the Canadian Society of Allery & Clinical Immunology, a Fellow of the Royal College of Physicians & Surgeons of Canada and American Academy of Allergy, Asthma & Clinical Immunology.

Dr. Yang’s early research has led him to discover the allergen in soybean protein, a research article was later published in the New England Journal of Medicine. Subsequent research in metabisulfite, a preservative in food, beverages and salad bars, has made him well recognized in the field nationally and internationally. He managed single-handedly to convince the government to ban the use of metabisulfite in the salads to protect asthmatics and allergy sufferers in this country. He was instrumental in raising the awareness of increasing mortality and morbidity in the country, asking government to fund workshops throughout the country, leading to the subsequent publication of the Canadian Asthma Consensus Guidelines.

He is the founder of Ottawa Allergy Research Corporation. He has also published over three hundred abstracts, manuscripts and book chapters in peer reviewed journals. He is actively involved in clinical trials for biotechnology and pharmaceutical companies. He is active in vaccine development involving H1N1, influenza, Covid etc. His research interest is also in hereditary angioedema (HAE) for over the last three decades, raising the HAE disease awareness and providing education for patients and health care providers and developing new treatment options for HAE sufferers. Yang Medicine is recognized as the Treatment and Reference Centre for HAEi International.

Also, a founder of Yang Medicine Yang Medicine Professional Corporation. It is recognized as Treatment (Biologic therapy) Centre of Excellence by the industry.

He co-founded Red Maple Trials Inc (RMT) which provides end-to-end services in allergy, asthma and immunology clinical research. RMT possess next generation clinical trial facilities highlighted by an Allergen Challenge Theatre plus a specialty focus CRO in allergy, asthma & clinical immunology, located in the nation’s capital. RMT is capable of executing on Phase 1-4 studies with 15 beds, in order to fulfill the challenging demands of our biopharmaceutical partners. 

Currently, in additional to HAE and vaccine research, he is active in studies on severe asthma, eosinophilic esophagitis (EoE), peanut allergy, atopic dermatitis, chronic spontaneous urticaria etc.